Article
Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models
24 Nov 2021
Abstract excerpt
Adeno-associated virus (AAV)-mediated CRISPR-Cas9 editing holds promise to treat many diseases. The immune response to bacterial-derived Cas9 has been speculated as a hurdle for AAV-CRISPR therapy. However, immunological consequences of AAV-mediated Cas9 expression have thus far not been thoroughly investigated in large mammals. We evaluate Cas9-specific immune responses in canine models of Duchenne muscular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
